LPS stimulation of complement (C3) synthesis by a human monocyte cell line

Area of Science:

• Immunology
• Cell Biology

Background:

• Monocytes and macrophages are key immune cells involved in inflammatory responses.
• Complement component C3 plays a crucial role in both innate and adaptive immunity.
• Understanding the regulation of C3 biosynthesis is vital for comprehending immune modulation.

Purpose of the Study:

• To investigate the effect of lipopolysaccharides (LPS) and other immunomodulatory agents on complement component C3 production in the U937 monocyte cell line.
• To determine the role of prostaglandin E2 (PGE2) in LPS-induced C3 biosynthesis.

Main Methods:

• U937 cells were cultured and treated with varying concentrations of Escherichia coli LPS, lymphokine-containing supernatants, and human gamma-interferon.
• Complement component C3 levels in the cell culture medium were quantified using an enzyme-linked immunosorbent assay (ELISA).
• The involvement of cycloheximide, PGE1, and indomethacin was assessed to elucidate the mechanisms of C3 production.

Main Results:

• LPS significantly increased C3 production in a dose-dependent manner (2- to 5-fold).
• Lymphokine-containing supernatants and gamma-interferon also stimulated C3 production.
• LPS-induced C3 synthesis was inhibited by cycloheximide, indicating a requirement for protein synthesis.
• LPS stimulated PGE2 production at higher concentrations, but not at the lowest effective C3-inducing concentration.
• Exogenous PGE1 had a minor effect, and indomethacin did not block LPS-induced C3 production, suggesting PGE2 is not the mediator.

Conclusions:

• Lipopolysaccharides and immune mediators modulate C3 biosynthesis in monocytoid cells.
• The mechanism of LPS-induced C3 synthesis in U937 cells does not appear to involve prostaglandin E2.
• These findings highlight the potential for immune mediators to regulate complement production in inflammatory microenvironments.